| Name | ABHD11 antisense RNA 1 (tail to tail) |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Long non‐coding RNA ABHD11‐AS1 is emerging as an important oncogenic regulator that is frequently upregulated in a variety of human cancers and is associated with aggressive clinicopathological features and poor patient prognosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": " In papillary thyroid carcinoma, ABHD11‐AS1 has been shown to promote cell proliferation and metastasis by enhancing PI3K/AKT signaling and acting as a competing endogenous RNA (ceRNA) that sponges microRNAs such as miR‑1301‑3p to upregulate factors like STAT3."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In digestive tumors, its elevated levels in gastric tissues and even gastric juice support its utility as a minimally invasive biomarker, while in colorectal cancer ABHD11‐AS1 contributes to tumor progression by sponging microRNAs (for example, miR‑1254 and miR‑133a) that normally suppress pro‐oncogenic targets such as WNT11 and SOX4."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Similarly, in gastric cancer, it modulates the miR‑361‑3p/PDPK1 axis, and in cervical cancer it sequesters miR‑330‑5p to upregulate MARK2, thereby facilitating cell migration and epithelial–mesenchymal transition."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " In pancreatic cancer, ABHD11‐AS1 has been implicated in the regulation of cyclin E1 and in the activation of the PI3K/AKT pathway to enhance cell proliferation, migration, and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Moreover, its oncogenic role is evident in other malignancies such as ovarian, bladder, and endometrial cancers, where it modulates key molecules – for instance, by interacting with EZH2 to silence tumor suppressors (e.g. TIMP2) in ovarian cancer, or by binding cyclin D1 to drive cell cycle progression in endometrial carcinoma."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "13"}]}, {"type": "t", "text": " Overall, these studies, along with recent reviews summarizing its multifaceted roles across tumor types"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ", highlight ABHD11‐AS1 as a promising candidate for diagnostic biomarker development and therapeutic targeting in cancer.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xi Zhuang, Houchao Tong, Yu Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-019-1850-4"}], "href": "https://doi.org/10.1038/s41419-019-1850-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31409775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31409775"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Juyi Wen, Hongwei Wang, Tingjun Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Prolif (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cpr.12569"}], "href": "https://doi.org/10.1111/cpr.12569"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30657221"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30657221"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yunben Yang, Yongfu Shao, Mengying Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-3903-3"}], "href": "https://doi.org/10.1007/s13277-015-3903-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26280398"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26280398"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Dedong He, Zhongyi Yue, Lingling Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ABHD11-AS1 promote cells proliferation and invasion of colorectal cancer via regulating the miR-1254-WNT11 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.27877"}], "href": "https://doi.org/10.1002/jcp.27877"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30537177"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30537177"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Xiaoyan Lei, Longchao Li, Xiaoyi Duan "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ABHD11-AS1 promotes colorectal cancer development through regulation of miR-133a/SOX4 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20181386"}], "href": "https://doi.org/10.1042/BSR20181386"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30429229"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30429229"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Hairong Xin, Zhifeng Yan, Jie Cao "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ABHD11-AS1 boosts gastric cancer development by regulating miR-361-3p/PDPK1 signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biochem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jb/mvaa065"}], "href": "https://doi.org/10.1093/jb/mvaa065"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32678870"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32678870"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Shunyu Hou, Xiaoqian Zhang, Jian Yang "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2021.112929"}], "href": "https://doi.org/10.1016/j.yexcr.2021.112929"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34793775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34793775"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Bowei Liu, Wei Wang, Suofeng Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Knockdown of lncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer via Sponging miR-1231."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Onco Targets Ther (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/OTT.S259598"}], "href": "https://doi.org/10.2147/OTT.S259598"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33177842"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33177842"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "X Qiao, S-X Lv, Y Qiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201812_16627"}], "href": "https://doi.org/10.26355/eurrev_201812_16627"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30575903"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30575903"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "H Lu, C Zhu, Y Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Transl Oncol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12094-021-02753-z"}], "href": "https://doi.org/10.1007/s12094-021-02753-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35098448"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35098448"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Xiang-Yang Zeng, Xiao-Yan Jiang, Jia-Hui Yong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.2586"}], "href": "https://doi.org/10.1002/cam4.2586"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31568657"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31568657"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Mingwei Chen, Jianfa Li, Chengle Zhuang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.14945"}], "href": "https://doi.org/10.18632/oncotarget.14945"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28157695"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28157695"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yao Liu, Li-Li Wang, Shuo Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.13675"}], "href": "https://doi.org/10.1111/jcmm.13675"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29799152"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29799152"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Upendarrao Golla, Kishore Sesham, Siva Dallavalasa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ABHD11-AS1: An Emerging Long Non-Coding RNA (lncRNA) with Clinical Significance in Human Malignancies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Noncoding RNA (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ncrna8020021"}], "href": "https://doi.org/10.3390/ncrna8020021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35314614"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35314614"}]}]}]}
|
| Synonyms | LINC00035, NCRNA00035, WBSCR26 |
| NCBI Gene ID | 171022 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
ABHD11-AS1 has 1,452 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 13 datasets.
Click the + buttons to view associations for ABHD11-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of ABHD11-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of ABHD11-AS1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of ABHD11-AS1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at ABHD11-AS1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of ABHD11-AS1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of ABHD11-AS1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of ABHD11-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ABHD11-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of ABHD11-AS1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of ABHD11-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of ABHD11-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at ABHD11-AS1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of ABHD11-AS1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |